Insider · CIK 0001412377
Marc Rubin
Files at CRIS (CURIS INC), GALT (GALECTIN THERAPEUTICS INC). First filing -, latest -.
In brief
Marc Rubin files SEC Form 4 as director at CRIS (CURIS INC), and also at GALT (GALECTIN THERAPEUTICS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marc Rubin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +6,800 | $5.29 | $36k | 6,800 | Jul 9, 2026 |
| Mar 20, 2026 | CRIS CURIS INC | CConversion Common Stock | +26,667 | - | - | 28,108 | Mar 23, 2026 |
| Mar 20, 2026 | CRIS CURIS INC | CConversion Series B Convertible Preferred Stockderivative | -20 | - | - | 0 | Mar 23, 2026 |
| Mar 17, 2026 | CRIS CURIS INC | AGrant or award Series B Convertible Preferred Stockderivative | +20 | - | - | 20 | Mar 18, 2026 |
| Mar 17, 2026 | CRIS CURIS INC | AGrant or award Series A Warrant (right to buy)derivative | +26,667 | - | - | 26,667 | Mar 18, 2026 |
| Mar 17, 2026 | CRIS CURIS INC | AGrant or award Series B Warrant (right to buy)derivative | +26,667 | - | - | 26,667 | Mar 18, 2026 |
| Mar 17, 2026 | CRIS CURIS INC | AGrant or award Series C Warrant (right to buy)derivative | +26,667 | - | - | 26,667 | Mar 18, 2026 |
| May 20, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +14,400 | $3.13 | $45k | 14,400 | May 22, 2025 |
| Jan 28, 2025 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +1,600 | $3.13 | $5,008 | 1,600 | Jan 30, 2025 |
| Jan 23, 2025 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Jan 27, 2025 |
| May 21, 2024 | CRIS CURIS INC | AGrant or award Non Qualified Stock Optionderivative | +4,250 | $11.62 | $49k | 4,250 | May 23, 2024 |
| Jan 24, 2024 | GALT GALECTIN THERAPEUTICS INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Feb 7, 2024 |
Questions about Marc Rubin
Answered from the filings on this page, as of the latest one.
Is Marc Rubin buying or selling?
Marc Rubin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marc Rubin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc Rubin has 0.
Where does Marc Rubin file Form 4?
Marc Rubin has filed Form 4 at CRIS (CURIS INC); GALT (GALECTIN THERAPEUTICS INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.